HuagongsheHuagongshe Chemistry Print Report · For research reference only
HRID 1035795Generated: October 30, 2026
Diisopropylethylamine → HCID 58046371, compound
https://huagongshe.com/reaction/1035795
Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | HCID 58046364 | HCID 58046364 | — |
| Reactant | tert-Butyl 2,9-diazaspiro[5.5]undecane-2-carboxylate--hydrogen chloride (1/1) | HCID 66570708 | — |
| Solvent | 1-Pentanol | HCID 6276 | — |
| Product | HCID 58046371 | HCID 58046371 | 0.1% |
Reaction Steps
A mixture of 0.15 g (0.29 mmol) of 6-chloro-2-(4-fluorophenyl)-3-[1-(4-methylphenylsulphonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]imidazo[1,2-b]pyridazine, prepared according to the method described in step 3.2 of Example 3, 0.337 g (1.15 mmol) of tert-butyl 2,9-diazaspiro[5.5]undecane-2-carboxylate hydrochloride (1:1) (CAS 1023301-88-3) and 0.224 g (1.7 mmol) of diisopropylethylamine in 2 ml of pentanol is heated under reflux for 40 hours at 140° C. The solvent is then evaporated under reduced pressure and the residue is purified by chromatography on a silica gel column by eluting with a gradient of dichloromethane, methanol and aqueous ammonia (of 100/0/0 to 90/10/1) in order to give 0.190 mg of tert-butyl 9-{2-(4-fluorophenyl)-3-[1-(4-methylphenylsulphonyl)-1H-pyrrolo[2,3-b]pyridin-4-yl]imidazo[1,2-b]pyridazin-6-yl}-2,9-diazaspiro[5.5]undecane-2-carboxylate after crystallization in methanol.
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US08546395B2 |
|---|
| Source dataset | uspto-grants-2013_10 |
|---|
| ORD ID | ord-8e4a1873c40e44cf89b86c168081986c |
|---|
| Source note | uspto-grants-2013_10 |
|---|